Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 1459497, 8 pages
https://doi.org/10.1155/2017/1459497
Review Article

The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity

1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China
2Experiment Center for Medical Science Research, Kunming Medical University, Kunming, Yunnan, China
3Department of Hematology and Oncology, The Children’s Hospital of Soochow, Jiangsu, China
4Department of Gastroenterology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China
5School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong
6Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China

Correspondence should be addressed to Zhangang Xiao; moc.liamtoh@898555gzx

Received 7 April 2017; Revised 20 July 2017; Accepted 2 August 2017; Published 24 August 2017

Academic Editor: Lin-sen Qing

Copyright © 2017 Yueshui Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Obesity: preventing and managing the global epidemic. Report of a WHO consultation,” World Health Organization Technical Report Series, vol. 894, no. i-xii, pp. 1–253, 2000.
  2. K. Sun, J. Tordjman, K. Clement, and P. E. Scherer, “Fibrosis and adipose tissue dysfunction,” Cell Metabolism, vol. 18, no. 4, pp. 470–477, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Cifarelli and S. D. Hursting, “Obesity, diabetes and cancer: a mechanistic perspective,” International Journal of Diabetology & Vascular Disease Research, vol. 2015, Supplement 4, 2015. View at Publisher · View at Google Scholar
  4. Y. Matsuzawa, I. Shimomura, T. Nakamura, Y. Keno, K. Kotani, and K. Tokunaga, “Pathophysiology and pathogenesis of visceral fat obesity,” Obesity Research, vol. 3, Supplement 2, pp. 187s–194s, 1995. View at Google Scholar
  5. V. B. Kalish, “Obesity in older adults,” Primary Care, vol. 43, no. 1, pp. 137–144, ix, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. E. Wozniak, L. L. Gee, M. S. Wachtel, and E. E. Frezza, “Adipose tissue: the new endocrine organ? A review article,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1847–1856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Sun, C. M. Kusminski, and P. E. Scherer, “Adipose tissue remodeling and obesity,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2094–2101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Chondronikola, E. Volpi, E. Børsheim et al., “Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans,” Cell Metabolism, vol. 23, no. 6, pp. 1200–1206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Cannon and J. Nedergaard, “Brown adipose tissue: function and physiological significance,” Physiological Reviews, vol. 84, no. 1, pp. 277–359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Oelkrug, E. T. Polymeropoulos, and M. Jastroch, “Brown adipose tissue: physiological function and evolutionary significance,” Journal of Comparative Physiology B, Biochemical, Systemic, and Environmental Physiology, vol. 185, no. 6, pp. 587–606, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Varela, A. Rodriguez, M. Romero-Valdovinos et al., “Browning effects of (-)-epicatechin on adipocytes and white adipose tissue,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  12. B. Thyagarajan and M. T. Foster, “Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans,” Hormone Molecular Biology and Clinical Investigation, 2017. View at Publisher · View at Google Scholar
  13. P. C. Dinas, A. Valente, M. Granzotto et al., “Browning formation markers of subcutaneous adipose tissue in relation to resting energy expenditure, physical activity and diet in humans,” 2017. View at Publisher · View at Google Scholar
  14. N. J. Song, S. H. Chang, D. Y. Li, C. J. Villanueva, and K. W. Park, “Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules,” Experimental & Molecular Medicine, vol. 49, no. 7, article e353, 2017. View at Publisher · View at Google Scholar
  15. V. Ryu, E. Zarebidaki, H. Elliott Albers, B. Xue, and T. J. Bartness, “Short photoperiod reverses obesity in Siberian hamsters via sympathetically induced lipolysis and browning in adipose tissue,” Physiology & Behavior, 2017. View at Publisher · View at Google Scholar
  16. B. Halpern, M. C. Mancini, and A. Halpern, “Brown adipose tissue: what have we learned since its recent identification in human adults,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 58, no. 9, pp. 889–899, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. W. D. Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders et al., “Cold-activated brown adipose tissue in healthy men,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1500–1508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Saito, Y. Okamatsu-Ogura, M. Matsushita et al., “High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity,” Diabetes, vol. 58, no. 7, pp. 1526–1531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Ouellet, S. M. Labbe, D. P. Blondin et al., “Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans,” The Journal of Clinical Investigation, vol. 122, no. 2, pp. 545–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Grant, “Metabolic reconfiguration is a regulated response to oxidative stress,” Journal of Biology, vol. 7, no. 1, p. 1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Bjorklund and S. Chirumbolo, “Role of oxidative stress and antioxidants in daily nutrition and human health,” Nutrition (Burbank, Los Angeles County, Calif.), vol. 33, pp. 311–321, 2017. View at Publisher · View at Google Scholar
  22. T. Wang, Y. Si, O. S. Shirihai et al., “Respiration in adipocytes is inhibited by reactive oxygen species,” Obesity (Silver Spring, Md.), vol. 18, no. 8, pp. 1493–1502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Matsuda and I. Shimomura, “Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk,” Hormone Molecular Biology and Clinical Investigation, vol. 19, no. 2, pp. 75–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Mopuri and M. S. Islam, “Medicinal plants and phytochemicals with anti-obesogenic potentials: a review,” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 89, pp. 1442–1452, 2017. View at Publisher · View at Google Scholar
  25. Y. Tang and R. Tsao, “Phytochemicals in quinoa and amaranth grains and their antioxidant, anti-inflammatory, and potential health beneficial effects: a review,” Molecular Nutrition & Food Research, vol. 61, no. 7, 2017. View at Publisher · View at Google Scholar
  26. J. Martel, D. M. Ojcius, C. J. Chang et al., “Anti-obesogenic and antidiabetic effects of plants and mushrooms,” Nature Reviews Endocrinology, vol. 13, no. 3, pp. 149–160, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. N. N. Sun, T. Y. Wu, and C. F. Chau, “Natural dietary and herbal products in anti-obesity treatment,” Molecules (Basel, Switzerland), vol. 21, no. 10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Balaji, M. S. Ganjayi, G. E. Hanuma Kumar, B. N. Parim, R. Mopuri, and S. Dasari, “A review on possible therapeutic targets to contain obesity: the role of phytochemicals,” Obesity Research & Clinical Practice, vol. 10, no. 4, pp. 363–380, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. J. Zhang, R. Y. Gan, S. Li et al., “Antioxidant phytochemicals for the prevention and treatment of chronic diseases,” Molecules (Basel, Switzerland), vol. 20, no. 12, pp. 21138–21156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. S. Deshpande, S. K. Sathe, and D. K. Salunkhe, “Chemistry and safety of plant polyphenols,” Advances in Experimental Medicine and Biology, vol. 177, pp. 457–495, 1984. View at Google Scholar
  31. L. Vamos-Vigyazo, “Polyphenol oxidase and peroxidase in fruits and vegetables,” Critical Reviews in Food Science and Nutrition, vol. 15, no. 1, pp. 49–127, 1981. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Haslam, T. H. Lilley, Y. Cai, R. Martin, and D. Magnolato, “Traditional herbal medicines—the role of polyphenols,” Planta Medica, vol. 55, no. 1, pp. 1–8, 1989. View at Publisher · View at Google Scholar
  33. C. Rice-Evans, “Plant polyphenols: free radical scavengers or chain-breaking antioxidants?” Biochemical Society Symposium, vol. 61, pp. 103–116, 1995. View at Google Scholar
  34. J. A. Dominguez Avila, J. Rodrigo Garcia, G. A. Gonzalez Aguilar, and L. A. Rosa, “The antidiabetic mechanisms of polyphenols related to increased glucagon-like peptide-1 (GLP1) and insulin signaling,” Molecules (Basel, Switzerland), vol. 22, no. 6, 2017. View at Publisher · View at Google Scholar
  35. J. Teixeira, D. Chavarria, F. Borges et al., “Dietary polyphenols and mitochondrial function: role in health and disease,” Current Medicinal Chemistry, 2017. View at Publisher · View at Google Scholar
  36. R. J. Nijveldt, E. Nood, D. E. Hoorn, P. G. Boelens, K. Norren, and P. A. Leeuwen, “Flavonoids: a review of probable mechanisms of action and potential applications,” The American Journal of Clinical Nutrition, vol. 74, no. 4, pp. 418–425, 2001. View at Google Scholar
  37. U. R. Kuppusamy and N. P. Das, “Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes,” Biochemical Pharmacology, vol. 44, no. 7, pp. 1307–1315, 1992. View at Google Scholar
  38. T. Motoyashiki, T. Morita, and H. Ueki, “Involvement of the rapid increase in cAMP content in the vanadate-stimulated release of lipoprotein lipase activity from rat fat pads,” Biological & Pharmaceutical Bulletin, vol. 19, no. 11, pp. 1412–1416, 1996. View at Google Scholar
  39. J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha, “The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways,” Biochemical and Biophysical Research Communications, vol. 373, no. 4, pp. 545–549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Herranz-López, I. Borras-Linares, M. Olivares-Vicente, J. Galvez, A. Segura-Carretero, and V. Micol, “Correlation between the cellular metabolism of quercetin and its glucuronide metabolite and oxidative stress in hypertrophied 3T3-L1 adipocytes,” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, vol. 25, pp. 25–28, 2017. View at Publisher · View at Google Scholar
  41. A. Leiherer, K. Stoemmer, A. Muendlein et al., “Quercetin impacts expression of metabolism- and obesity-associated genes in SGBS adipocytes,” Nutrients, vol. 8, no. 5, p. 282, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. C. R. Yeo, M. Agrawal, S. Hoon et al., “SGBS cells as a model of human adipocyte browning: a comprehensive comparative study with primary human white subcutaneous adipocytes,” Scientific Reports, vol. 7, no. 1, p. 4031, 2017. View at Publisher · View at Google Scholar
  43. S. Carobbio, V. Pellegrinelli, and A. Vidal-Puig, “Adipose tissue function and expandability as determinants of lipotoxicity and the metabolic syndrome,” Advances in Experimental Medicine and Biology, vol. 960, pp. 161–196, 2017. View at Publisher · View at Google Scholar
  44. M. Okla, J. Kim, and K. Koehler, “Dietary factors promoting brown and beige fat development and thermogenesis,” Advances in Nutrition (Bethesda, Md.), vol. 8, no. 3, pp. 473–483, 2017. View at Publisher · View at Google Scholar
  45. S. G. Lee, J. S. Parks, and H. W. Kang, “Quercetin, a functional compound of onion peel, remodels white adipocytes to brown-like adipocytes,” The Journal of Nutritional Biochemistry, vol. 42, pp. 62–71, 2017. View at Publisher · View at Google Scholar
  46. X. Zhou, J. Xu, Y. Shi, and J. M. Ye, “Discovery of novel anti-diabetic drugs by targeting lipid metabolism,” Current Drug Targets, vol. 16, no. 12, pp. 1372–1380, 2015. View at Google Scholar
  47. C. Liang, M. E. Oest, and M. R. Prater, “Intrauterine exposure to high saturated fat diet elevates risk of adult-onset chronic diseases in C57BL/6 mice,” Birth Defects Research Part B, Developmental and Reproductive Toxicology, vol. 86, no. 5, pp. 377–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Rivera, R. Moron, M. Sanchez, A. Zarzuelo, and M. Galisteo, “Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats,” Obesity (Silver Spring, Md.), vol. 16, no. 9, pp. 2081–2087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. L. K. Stewart, J. L. Soileau, D. Ribnicky et al., “Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet,” Metabolism: Clinical and Experimental, vol. 57, Supplement 1, no. 7, pp. S39–S46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Moon, H. J. Do, O. Y. Kim, and M. J. Shin, “Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats,” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, vol. 58, pp. 347–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Kobori, Y. Takahashi, M. Sakurai et al., “Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice,” Molecular Nutrition & Food Research, vol. 60, no. 2, pp. 300–312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Dong, X. Zhang, L. Zhang et al., “Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1/SIRT1,” Journal of Lipid Research, vol. 55, no. 3, pp. 363–374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. S. K. Panchal, H. Poudyal, and L. Brown, “Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats,” The Journal of Nutrition, vol. 142, no. 6, pp. 1026–1032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. J.-S. Lee, Y.-J. Cha, K.-H. Lee, and J.-E. Yim, “Onion peel extract reduces the percentage of body fat in overweight and obese subjects: a 12-week, randomized, double-blind, placebo-controlled study,” Nutrition Research Practice, vol. 10, no. 2, pp. 175–181, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Pfeuffer, A. Auinger, U. Bley et al., “Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms,” Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, vol. 23, no. 5, pp. 403–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. K. Yang and S. P. Kim, “The effect of onion extract intake for 12 weeks on blood lipid and obesity index in obese university women,” Korean Journal of Sports Sciences, vol. 22, pp. 955–962, 2013. View at Google Scholar
  57. K. H. Lee, H. J. Lee, E. J. Park, and K. I. Jeon, “Effect of onion extracts on serum lipid and antioxidant status in healthy university female,” Korean Journal of Community Nutrition, vol. 2, 2008. View at Google Scholar
  58. Trials.gov C, “Investigating the use of quercetin on glucose absorption in obesity, and obesity with type 2 diabetes,” 2017, http://clinicaltrials.gov/show/NCT00065676, 2013.
  59. R. A. Shanely, A. M. Knab, D. C. Nieman, F. Jin, S. R. McAnulty, and M. J. Landram, “Quercetin supplementation does not alter antioxidant status in humans,” Free Radical Research, vol. 44, no. 2, pp. 224–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Strimpakos and R. A. Sharma, “Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials,” Antioxidants & Redox Signaling, vol. 10, no. 3, pp. 511–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Y. Kim, T. T. Le, C. Chen, J. X. Cheng, and K. H. Kim, “Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion,” The Journal of Nutritional Biochemistry, vol. 22, no. 10, pp. 910–920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Ahn, H. Lee, S. Kim, and T. Ha, “Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling,” American Journal of Physiology Cell Physiology, vol. 298, no. 6, pp. C1510–C1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Gurnell, “Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 19, no. 4, pp. 501–523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. H. M. Woo, J. H. Kang, T. Kawada, H. Yoo, M. K. Sung, and R. Yu, “Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes,” Life Sciences, vol. 80, no. 10, pp. 926–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Asai and T. Miyazawa, “Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue,” The Journal of Nutrition, vol. 131, no. 11, pp. 2932–2935, 2001. View at Google Scholar
  66. W. Shao, Z. Yu, Y. Chiang et al., “Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes,” PLoS One, vol. 7, no. 1, article e28784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. S. P. Weisberg, R. Leibel, and D. V. Tortoriello, “Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity,” Endocrinology, vol. 149, no. 7, pp. 3549–3558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Mohammadi, A. Sahebkar, M. Iranshahi et al., “Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial,” Phytotherapy Research: PTR, vol. 27, no. 3, pp. 374–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Ganjali and A. Sahebkar, “Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial,” The Scientific World Journal, vol. 2014, Article ID 898361, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Sahebkar, A. Mohammadi, A. Atabati et al., “Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals,” Phytotherapy Research: PTR, vol. 27, no. 12, pp. 1883–1888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. “Evaluation of certain food additives,” Tech. Rep., WHO Technical Report Series, 891, WHO, Geneva, 2000.
  72. M. Liddle, C. Hull, C. Liu, and D. Powell, “Contact urticaria from curcumin,” Dermatitis: Contact, Atopic, Occupational, Drug, vol. 17, no. 4, pp. 196-197, 2006. View at Google Scholar
  73. N. Dhillon, B. B. Aggarwal, R. A. Newman et al., “Phase II trial of curcumin in patients with advanced pancreatic cancer,” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol. 14, no. 14, pp. 4491–4499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Meydani and S. T. Hasan, “Dietary polyphenols and obesity,” Nutrients, vol. 2, no. 7, pp. 737–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. U. Stervbo, O. Vang, and C. Bonnesen, “A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine,” Food Chemistry, vol. 101, no. 2, pp. 449–457, 2007. View at Google Scholar
  76. J. Burns, T. Yokota, H. Ashihara, M. E. Lean, and A. Crozier, “Plant foods and herbal sources of resveratrol,” Journal of Agricultural and Food Chemistry, vol. 50, no. 11, pp. 3337–3340, 2002. View at Google Scholar
  77. W. J. Spuy and E. Pretorius, “Is the use of resveratrol in the treatment and prevention of obesity premature?” Nutrition Research Reviews, vol. 22, no. 2, pp. 111–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. Z. E. Floyd, Z. Q. Wang, G. Kilroy, and W. T. Cefalu, “Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol,” Metabolism, vol. 57, Supplement 1, no. 7, pp. S32–S38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Rayalam, J. Y. Yang, S. Ambati, M. A. Della-Fera, and C. A. Baile, “Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes,” Phytotherapy Research: PTR, vol. 22, no. 10, pp. 1367–1371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Imamura, D. Nagayama, N. Ishihara et al., “Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes,” Molecular Genetics and Metabolism Reports, vol. 12, pp. 44–50, 2017. View at Publisher · View at Google Scholar
  81. K. Szkudelska, L. Nogowski, and T. Szkudelski, “Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 113, no. 1-2, pp. 17–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Gomez-Zorita, K. Treguer, J. Mercader, and C. Carpene, “Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells,” Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 585–593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Fischer-Posovszky, V. Kukulus, D. Tews et al., “Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner,” The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 5–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Kang, W. Heng, A. Yuan, L. Baolin, and H. Fang, “Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses,” Biochimie, vol. 92, no. 7, pp. 789–796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Olholm, S. K. Paulsen, K. B. Cullberg, B. Richelsen, and S. B. Pedersen, “Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants,” International Journal of Obesity (2005), vol. 34, no. 10, pp. 1546–1553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. I. Zagotta, E. Y. Dimova, K. M. Debatin, M. Wabitsch, T. Kietzmann, and P. Fischer-Posovszky, “Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue,” Frontiers in Pharmacology, vol. 6, p. 79, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. K. B. Cullberg, J. Olholm, S. K. Paulsen et al., “Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro,” European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, vol. 49, no. 2, pp. 251–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. S. J. Cho, U. J. Jung, and M. S. Choi, “Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice,” The British Journal of Nutrition, vol. 108, no. 12, pp. 2166–2175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Kim, Y. Jin, Y. Choi, and T. Park, “Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice,” Biochemical Pharmacology, vol. 81, no. 11, pp. 1343–1351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. C. R. Ku, Y. H. Cho, Z. Y. Hong et al., “The effects of high fat diet and resveratrol on mitochondrial activity of brown adipocytes,” Endocrinology and Metabolism (Seoul, Korea), vol. 31, no. 2, pp. 328–335, 2016. View at Publisher · View at Google Scholar · View at Scopus
  92. G. Alberdi, V. M. Rodriguez, J. Miranda, M. T. Macarulla, I. Churruca, and M. P. Portillo, “Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats,” Food Chemistry, vol. 141, no. 2, pp. 1530–1535, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Arias, C. Pico, M. Teresa Macarulla et al., “A combination of resveratrol and quercetin induces browning in white adipose tissue of rats fed an obesogenic diet,” Obesity (Silver Spring, Md.), vol. 25, no. 1, pp. 111–121, 2017. View at Publisher · View at Google Scholar
  94. S. Wang, X. Liang, Q. Yang et al., “Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) alpha1,” International Journal of Obesity (2005), vol. 39, no. 6, pp. 967–976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. B. T. Jeon, E. A. Jeong, H. J. Shin et al., “Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet,” Diabetes, vol. 61, no. 6, pp. 1444–1454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. B. Wang, J. Sun, X. Li et al., “Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity,” Nutrition Research (New York, N.Y.), vol. 33, no. 11, pp. 971–981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Gomez-Zorita, A. Fernandez-Quintela, A. Lasa, E. Hijona, L. Bujanda, and M. P. Portillo, “Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats,” Nutrition (Burbank, Los Angeles County, Calif.), vol. 29, no. 11-12, pp. 1374–1380, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Jimenez-Gomez, J. A. Mattison, K. J. Pearson et al., “Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet,” Cell Metabolism, vol. 18, no. 4, pp. 533–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. Z. M. Lv, Q. Wang, Y. H. Chen, S. H. Wang, and D. Q. Huang, “Resveratrol attenuates inflammation and oxidative stress in epididymal white adipose tissue: implications for its involvement in improving steroidogenesis in diet-induced obese mice,” Molecular Reproduction and Development, vol. 82, no. 4, pp. 321–328, 2015. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Timmers, M. K. Hesselink, and P. Schrauwen, “Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?” Annals of the New York Academy of Sciences, vol. 1290, pp. 83–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Timmers, E. Konings, L. Bilet et al., “Calorie restriction-like effects of 30 days of resveratrol (resVida™) supplementation on energy metabolism and metabolic profile in obese humans,” Cell Metabolism, vol. 14, no. 5, pp. 612–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Konings, S. Timmers, M. V. Boekschoten et al., “The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men,” International Journal of Obesity (2005), vol. 38, no. 3, pp. 470–473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. M. M. Poulsen, P. F. Vestergaard, B. F. Clasen et al., “High-dose resveratrol supplementation in obese men. An investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition,” Diabetes, vol. 62, no. 4, pp. 1186–1195, 2013. View at Publisher · View at Google Scholar · View at Scopus